Xingjuan Chao - May 15, 2025 Form 4 Insider Report for Ceribell, Inc. (CBLL)

Role
President and CEO, Director
Signature
/s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao
Stock symbol
CBLL
Transactions as of
May 15, 2025
Transactions value $
-$348,940
Form type
4
Date filed
5/19/2025, 12:33 PM
Previous filing
Sep 12, 2025
Next filing
Jun 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chao Xingjuan President and CEO, Director C/O CERIBELL, INC., 360 N. PASTORIA AVENUE, SUNNYVALE /s/ Louisa Daniels, Attorney-in-Fact for Xingjuan (Jane) Chao 2025-05-19 0002035784

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBLL Common Stock Options Exercise $56K +25K +3.44% $2.24 752K May 15, 2025 Direct F1
transaction CBLL Common Stock Sale -$424K -25K -3.32% $16.96 727K May 15, 2025 Direct F1, F2
transaction CBLL Common Stock Options Exercise $19.1K +48.9K +6.72% $0.39 776K May 15, 2025 Direct
holding CBLL Common Stock 369K May 15, 2025 By ACP 2021 Trust F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBLL Stock Option (Right to Buy) Options Exercise $0 -25K -19.6% $0.00 103K May 15, 2025 Common Stock 25K $2.24 Direct F1, F5
transaction CBLL Stock Option (Right to Buy) Options Exercise $0 -48.9K -100% $0.00 0 May 15, 2025 Common Stock 48.9K $0.39 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.08 to $17.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
F3 The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
F4 The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F5 The option was granted on November 10, 2015 and is fully vested and exercisable as of the transaction date.
F6 The option was granted on July 7, 2021 and is fully vested and exercisable as of the transaction date.